Mach-1 Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,314
Closed -$406K 255
2025
Q4
$406K Buy
+16,314
New +$411K 0.08% 185
2024
Q1
Sell
-31,234
Closed -$899K 177
2023
Q4
$899K Sell
31,234
-1,755
-5% -$53.1K 0.34% 65
2023
Q3
$1.09M Sell
32,989
-21,993
-40% -$778K 0.45% 54
2023
Q2
$2.02M Buy
54,982
+51,557
+1,505% +$2.01M 0.57% 40
2023
Q1
$125K Sell
3,425
-20,210
-86% -$873K 0.8% 33
2022
Q4
$1.21M Buy
23,635
+20,375
+625% +$977K 0.4% 39
2022
Q3
$142K Buy
3,260
+205
+7% +$9.96K 0.15% 52
2022
Q2
$159K Buy
3,055
+2,755
+918% +$140K 0.11% 52
2022
Q1
$15K Sell
300
-89
-23% -$4.62K 0.01% 103
2021
Q4
$22K Buy
+389
New +$19.3K 0.01% 82
2021
Q3
Sell
-300
Closed -$11K 109
2021
Q2
$11K Hold
300
0.01% 84
2021
Q1
$10K Sell
300
-716
-70% -$25.4K 0.01% 115
2020
Q4
$37K Buy
+1,016
New +$37.3K 0.04% 77

Other funds holding PFE

Mach-1 Financial Group's PFE Position: Q1 2026 in Review

Mach-1 Financial Group sold out of Pfizer (PFE) in Q1 2026, closing a stake of 16,314 shares — an estimated $406K sold.

Mach-1 Financial Group first reported a position in PFE in Q4 2020 and held it in 13 quarters. The position peaked at $2.02M in Q2 2023. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mach-1 Financial Group reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Mach-1 Financial Group sold 16,314 Pfizer shares in Q1 2026, an estimated $406K.
  • Mach-1 Financial Group first reported a position in Pfizer in Q4 2020 and held it in 13 quarters.
  • Mach-1 Financial Group's Pfizer position peaked at $2.02M in Q2 2023.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mach-1 Financial Group's 13F filing for Q1 2026, filed 13 May 2026.